Publication | Closed Access

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune DiseaseRheumatic DiseasesRandomised TrialPharmacologyPsoriatic ArthritisEarly Rheumatoid ArthritisInflammatory Rheumatic DiseasePharmacotherapySwefot TrialMedicineRheumatoid Arthritis